Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
5 pending office actions • 2 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Innospec Limited is currently managing 5 pending office actions within the Chemistry & Materials technology area. These matters are distributed among 3 distinct examiners. The portfolio is active across 2 distinct art units, indicating that the company's chemical research is being reviewed in 2 different technical classifications. This structure suggests that while the company has 5 pending office actions, the technical breadth is limited to 2 distinct art units.
CEPHIA D TOOMER is the busiest examiner for the company, overseeing 2 busiest examiner pending office actions. This means that this examiner is responsible for 2 of the 5 pending office actions. The remaining 3 pending office actions are split between the other 2 distinct examiners. This concentration of work with 2 busiest examiner pending office actions indicates that certain technical themes may be clustered under CEPHIA D TOOMER. With 3 distinct examiners involved, the company must balance its strategy across different individual styles while maintaining consistency within the 2 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOOMER, CEPHIA D | 2 | 74.4% | +2.5% |
| HINES, LATOSHA D | 2 | 51.2% | +21.7% |
| PAUL, SHREYA | 1 | 100.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18572737 | EDDS ADDUCT COMPOSITIONS | PAUL, SHREYA | 9d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18859441 | USE AND METHOD | TOOMER, CEPHIA D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18394511 | COMPOSITION, METHOD AND USE | HINES, LATOSHA D | 76d |
| 18394507 | COMPOSITION, METHOD AND USE | HINES, LATOSHA D | — |
| Art Unit | Apps |
|---|---|
| 1771 | 4 |
| 1761 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18859448 | USE AND METHOD | TOOMER, CEPHIA D | 1771 | §103 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18859441 | USE AND METHOD | TOOMER, CEPHIA D | 1771 | §103§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18394511 | COMPOSITION, METHOD AND USE | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | 76d | Pending | Dec 22, 2023 |
| 18394507 | COMPOSITION, METHOD AND USE | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18572737 | EDDS ADDUCT COMPOSITIONS | PAUL, SHREYA | 1761 | §103 | Final Rejection | 9d overdue | Pending | Dec 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial